Written by
Reviewed by
Normal range
Non-smoker: < 2.5 ng/mL; Smoker: < 5 ng/mL
Introduction
Carcinoembryonic Antigen (CEA) is a protein that plays a fascinating role in your body's development and ongoing health monitoring. Before birth, CEA helps with normal tissue development, but by the time you're born, detectable levels in your blood disappear. In healthy adults, CEA levels remain very low, so when levels rise, it provides doctors with valuable information about various health conditions requiring attention, such as intestinal cancer.
CEA testing serves as a specialised monitoring tool rather than a routine screening test. Not all cancers produce CEA, and a level within the normal range doesn't guarantee that disease isn't present, which is why doctors use this test strategically for specific situations rather than general population screening. Understanding CEA helps you appreciate one of medicine's most valuable monitoring tools for people who need ongoing health surveillance.
When CEA Testing Becomes Valuable
Most healthy adults have very low CEA levels, typically less than 3 ng/mL, reflecting the protein's normal developmental role that largely ends after birth. CEA testing becomes particularly valuable for people who've been treated for certain conditions, especially bowel-related or abdominal cancers, where ongoing monitoring provides crucial health information.
The test's value lies in tracking trends over time rather than single measurements. Rising levels often provide the first indication that further investigation is needed, whilst stable low levels offer reassurance that previous treatments remain effective.
What Influences Your CEA Levels
Smoking significantly affects CEA levels, with smokers typically showing higher baseline measurements than non-smokers. If you smoke, your doctor will consider this when interpreting results, as elevated levels in smokers don't necessarily indicate the same concerns as in non-smokers.
Increased CEA concentrations can indicate some non-cancer-related conditions, such as liver disease and inflammatory bowel disease. These benign causes explain why doctors always consider your complete medical picture when reviewing results.
Age and individual variation naturally influence CEA levels, with some people producing slightly more of this protein than others. Additionally, certain medications, recent procedures, and temporary illnesses can affect measurements, which is why doctors often repeat testing to confirm results and establish reliable baselines.
The protein's sensitivity to various conditions makes it valuable for monitoring but requires careful interpretation. This is why CEA testing works best as part of comprehensive health assessment rather than as an isolated measurement.
5 habits that boost your longevity
Get a doctor-reviewed 5-day guide to diet, exercise, sleep, lifestyle and mental wellbeing. Practical, evidence-based, and ready to start today.
No spam. Unsubscribe anytime. By continuing, you agree to receive occasional updates from Emerald. See our Privacy Policy.
CEA's Role in Health Monitoring
CEA excels as a monitoring tool for people undergoing treatment for specific conditions, particularly those involving digestive system concerns. When CEA decreases to "normal" concentrations after therapy, it means that the CEA-producing tumour has been removed, providing reassurance that treatment has been successful.
CEA has been found helpful in monitoring some patients with cancer of the rectum, lung, breast, liver, pancreas, stomach, and ovary, though its primary use remains in digestive system conditions where it provides the most reliable information.
Understanding Your Results
Reference Ranges:
Normal levels: Less than 3 ng/mL (3 μg/L)
Smokers: May have naturally elevated baseline levels (such as 0 to 5 µg/L)
Elevated Levels:
Mildly elevated: 3-10 ng/mL
Moderately elevated: 10-20 ng/mL
Significantly elevated: Greater than 20 ng/mL
Trend analysis often provides more valuable information than individual measurements. Your healthcare team will track changes over time to distinguish between temporary fluctuations and patterns requiring medical attention. For people requiring regular CEA monitoring, your doctor will explain what changes to watch for and establish appropriate testing schedules based on your individual risk factors and medical history.
Longevity starts with awareness
Less than £1/day. Test 124 biomarkers. Personalised plan and 1:1 GP support.
The Takeaway
CEA serves as a valuable monitoring protein for specific situations. Normal levels offer reassurance about your current health status, whilst changes provide opportunities for early medical evaluation and intervention.
Understanding CEA results empowers you to work effectively with your healthcare team, whether for routine monitoring or addressing specific health concerns.
References
National Institute for Health and Care Excellence. (2011). Colorectal cancer: diagnosis and management. NICE Guideline CG131.
Lab Tests Online UK. (2024). Carcinoembryonic Antigen (CEA). Association for Clinical Biochemistry & Laboratory Medicine.
North Bristol NHS Trust. (2024). CEA Testing Guidelines and Clinical Use. NHS Foundation Trust Laboratory Services.
Cleveland Clinic. (2025). CEA Test (Carcinoembryonic Antigen): Clinical Applications. Cleveland Clinic Medical References.














